- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/26 - Interleukin-2
Patent holdings for IPC class C12N 15/26
Total number of patents in this class: 107
10-year publication summary
|
3
|
2
|
10
|
15
|
20
|
6
|
7
|
12
|
6
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Medicenna Therapeutics Inc. | 42 |
4 |
| Roche Glycart AG | 136 |
4 |
| Innovent Biologics (Suzhou) Co., Ltd. | 291 |
4 |
| Tilt Biotherapeutics Oy | 31 |
3 |
| Synthorx, Inc. | 48 |
3 |
| Shanghai GP Biotech Co. Ltd. | 4 |
3 |
| Leto Laboratories Co., Ltd | 21 |
3 |
| Amgen Inc. | 4425 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6644 |
2 |
| Jiangsu Hengrui Medicine Co., Ltd. | 694 |
2 |
| Nektar Therapeutics | 407 |
2 |
| ProLynx LLC | 60 |
2 |
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 712 |
2 |
| Soonchunhyang University Industry Academy Cooperation Foundation | 209 |
2 |
| Wuxi Biologics (Shanghai) Co. Ltd. | 173 |
2 |
| WuXi Biologics Ireland Limited | 283 |
2 |
| Adlai Nortye Biopharma Co., Ltd. | 77 |
2 |
| Shanghai Shengdi Pharmaceutical Co., Ltd | 164 |
2 |
| Akron BioProducts, LLC | 20 |
2 |
| Beijing Jingtai Technology Co., Ltd. | 11 |
2 |
| Other owners | 57 |